130 related articles for article (PubMed ID: 36859809)
1. Coagulation factor dysregulation in polycystic ovary syndrome is an epiphenomenon of obesity.
Moin ASM; Sathyapalan T; Butler AE; Atkin SL
Clin Endocrinol (Oxf); 2023 Jun; 98(6):796-802. PubMed ID: 36859809
[TBL] [Abstract][Full Text] [Related]
2. Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome.
Moin ASM; Sathyapalan T; Diboun I; Elrayess MA; Butler AE; Atkin SL
Sci Rep; 2021 Mar; 11(1):5320. PubMed ID: 33674695
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory Markers in Non-Obese Women with Polycystic Ovary Syndrome Are Not Elevated and Show No Correlation with Vitamin D Metabolites.
Moin ASM; Sathyapalan T; Atkin SL; Butler AE
Nutrients; 2022 Aug; 14(17):. PubMed ID: 36079796
[TBL] [Abstract][Full Text] [Related]
4. Classical and alternate complement factor overexpression in non-obese weight matched women with polycystic ovary syndrome does not correlate with vitamin D.
Moin ASM; Sathyapalan T; Butler AE; Atkin SL
Front Endocrinol (Lausanne); 2022; 13():935750. PubMed ID: 36619572
[TBL] [Abstract][Full Text] [Related]
5. Fibrin lysability is associated with central obesity and inflammation in women with polycystic ovary syndrome.
Godtfredsen ACM; Sidelmann JJ; Gram JB; Andersen M; Glintborg D
Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1078-1084. PubMed ID: 32048272
[TBL] [Abstract][Full Text] [Related]
6. A Cross-Sectional Exploratory Study of Cardiovascular Risk Biomarkers in Non-Obese Women with and without Polycystic Ovary Syndrome: Association with Vitamin D.
Nandakumar M; Das P; Sathyapalan T; Butler AE; Atkin SL
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928037
[TBL] [Abstract][Full Text] [Related]
7. High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome.
Butler AE; Moin ASM; Reiner Ž; Sathyapalan T; Jamialahmadi T; Sahebkar A; Atkin SL
Front Endocrinol (Lausanne); 2023; 14():1117761. PubMed ID: 37181037
[TBL] [Abstract][Full Text] [Related]
8. A Cross-Sectional Study of Protein Changes Associated with Dementia in Non-Obese Weight Matched Women with and without Polycystic Ovary Syndrome.
Butler AE; Moin ASM; Sathyapalan T; Atkin SL
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397086
[TBL] [Abstract][Full Text] [Related]
9. Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients.
Butler AE; Moin ASM; Sathyapalan T; Atkin SL
Cells; 2023 Aug; 12(15):. PubMed ID: 37566081
[TBL] [Abstract][Full Text] [Related]
10. Associations between insulin resistance, free fatty acids, and oocyte quality in polycystic ovary syndrome during in vitro fertilization.
Niu Z; Lin N; Gu R; Sun Y; Feng Y
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2269-76. PubMed ID: 24694334
[TBL] [Abstract][Full Text] [Related]
11. Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
El-Eshmawy MM; Ibrahim A; Bahriz R; Shams-Eldin N; Mahsoub N
BMC Endocr Disord; 2022 Dec; 22(1):315. PubMed ID: 36514085
[TBL] [Abstract][Full Text] [Related]
12. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
[TBL] [Abstract][Full Text] [Related]
13. Increased MicroRNA Levels in Women With Polycystic Ovarian Syndrome but Without Insulin Resistance: A Pilot Prospective Study.
Butler AE; Ramachandran V; Cunningham TK; David R; Gooderham NJ; Benurwar M; Dargham SR; Hayat S; Sathyapalan T; Najafi-Shoushtari SH; Atkin SL
Front Endocrinol (Lausanne); 2020; 11():571357. PubMed ID: 33101204
[TBL] [Abstract][Full Text] [Related]
14. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.
Silfen ME; Denburg MR; Manibo AM; Lobo RA; Jaffe R; Ferin M; Levine LS; Oberfield SE
J Clin Endocrinol Metab; 2003 Oct; 88(10):4682-8. PubMed ID: 14557441
[TBL] [Abstract][Full Text] [Related]
15. Changes in sexual function among women with polycystic ovary syndrome: a pilot study.
Ferraresi SR; Lara LA; Reis RM; Rosa e Silva AC
J Sex Med; 2013 Feb; 10(2):467-73. PubMed ID: 23210985
[TBL] [Abstract][Full Text] [Related]
16. Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome.
Mannerås-Holm L; Baghaei F; Holm G; Janson PO; Ohlsson C; Lönn M; Stener-Victorin E
J Clin Endocrinol Metab; 2011 Apr; 96(4):1068-76. PubMed ID: 21252248
[TBL] [Abstract][Full Text] [Related]
17. Oxidative Stress Markers and Heat Shock Proteins in Non-Obese Women with Polycystic Ovary Syndrome Are Not Elevated and Show No Correlation with Vitamin D.
Nandakumar M; Sathyapalan T; Butler AE; Atkin SL
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509682
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular myocardial mass index and its correlates as an early marker of cardiovascular risk among nonobese normotensive Indian women with polycystic ovary syndrome: lessons from a cross-sectional study.
Rashid A; Masood A; Wani IA; Hafeez I; Parvez T; Zagar MA; Ganie MA
Fertil Steril; 2020 Jun; 113(6):1299-1307.e2. PubMed ID: 32482259
[TBL] [Abstract][Full Text] [Related]
19. Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS).
Atiomo WU; Fox R; Condon JE; Shaw S; Friend J; Prentice AG; Wilkin TJ
Clin Endocrinol (Oxf); 2000 Apr; 52(4):487-92. PubMed ID: 10762292
[TBL] [Abstract][Full Text] [Related]
20. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
